Med Ad News 200 — World's Best-Selling Medicines
Lipitor’s overall global sales declined in 2007 for the first year since the cholesterol medicine entered the U.S. arena during first-quarter 1997. The antiplatelet agent Plavix is the second best seller and the respiratory drug Advair ranks No. 3.
By Andrew Humphreys

The Thin Web Line
With blogs and patient communities proliferating on the Internet, pharmaceutical marketers are beginning to face the challenge of defending their brands’ reputations online.
By Joshua Slatko

Pharma Tunes in to 2.0
Reluctance by the pharmaceutical industry to actively participate in social networking sites and communities stems from regulatory concerns, but marketers are listening in on the dialogue.
By Gina-Louise Monari

Sales & Marketing
Diabetes medications have vaulted past lipid-lowering drugs as the leading driver of prescription product spending growth.
By Joshua Slatko

Pharma Business
The board of directors of Enzon Pharmaceuticals Inc. has authorized a plan to spin off the company’s novel biotech business.
By Steven Niles

People on the Move
Eli Lilly and Co. is making changes across its executive leadership structure as the company continues to position itself to compete and win in a challenging business environment.
By Gina-Louise Monari

Adwise
Medicus LifeBrands has been created following the combination of two of Publicis Healthcare Communications Group’s flagship advertising agencies.
By Gina-Louise Monari

e-marketing
The much-touted lack of faith that consumers are assumed to have for online pharmaceutical-sponsored health resources may be greatly exaggerated.
By Joshua Slatko

FDA Files
A series of proposed label changes by FDA are intended to provide better information about the effects of medicines used during pregnancy and breast-feeding.
By Steven Niles

Drug Approvals
FDA has cleared a new form of GlaxoSmithKline’s Advair Diskus, and the company has added three new product approvals in Europe.
By Gina-Louise Monari

Small companies turn to blogs
Tolerx is the first company within the small biotechnology sector to introduce a corporate blog to its Website.